| M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy LH Beck Jr, RGB Bonegio, G Lambeau, DM Beck, DW Powell, ... New England Journal of Medicine 361 (1), 11-21, 2009 | 2697 | 2009 |
| Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy NM Tomas, LH Beck Jr, C Meyer-Schwesinger, B Seitz-Polski, H Ma, ... New England Journal of Medicine 371 (24), 2277-2287, 2014 | 986 | 2014 |
| Vascular development: cellular and molecular regulation L Beck Jr, PA D'Amore The FASEB journal 11 (5), 365-373, 1997 | 815 | 1997 |
| Anti-phospholipase A2 receptor antibody in membranous nephropathy W Qin, LH Beck Jr, C Zeng, Z Chen, S Li, K Zuo, DJ Salant, Z Liu Journal of the American Society of Nephrology 22 (6), 1137-1143, 2011 | 575 | 2011 |
| Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy LH Beck Jr, FC Fervenza, DM Beck, RGB Bonegio, FA Malik, SB Erickson, ... Journal of the American Society of Nephrology 22 (8), 1543-1550, 2011 | 563 | 2011 |
| Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy JM Hofstra, LH Beck Jr, DM Beck, JF Wetzels, DJ Salant Clinical journal of the American Society of Nephrology 6 (6), 1286-1291, 2011 | 473 | 2011 |
| Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact KK Hirschi, SA Rohovsky, LH Beck, SR Smith, PA D’Amore Circulation research 84 (3), 298-305, 1999 | 431 | 1999 |
| Membranous nephropathy: recent travels and new roads ahead LH Beck Jr, DJ Salant Kidney international 77 (9), 765-770, 2010 | 276 | 2010 |
| An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain–containing 7A–specific antibodies in membranous nephropathy E Hoxha, LH Beck Jr, T Wiech, NM Tomas, C Probst, S Mindorf, ... Journal of the American Society of Nephrology 28 (2), 520-531, 2017 | 221 | 2017 |
| The role of complement in membranous nephropathy H Ma, DG Sandor, LH Beck Jr Seminars in nephrology 33 (6), 531-542, 2013 | 213 | 2013 |
| Membranous nephropathy: from models to man LH Beck, DJ Salant The Journal of clinical investigation 124 (6), 2307-2314, 2014 | 202 | 2014 |
| Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology AJB Watts, KH Keller, G Lerner, I Rosales, AB Collins, M Sekulic, ... Journal of the American Society of Nephrology 33 (1), 238-252, 2022 | 184 | 2022 |
| Membranous nephropathy: a journey from bench to bedside JM Francis, LH Beck Jr, DJ Salant American Journal of Kidney Diseases 68 (1), 138-147, 2016 | 165 | 2016 |
| Membranous nephropathy: core curriculum 2021 L Alsharhan, LH Beck Jr American journal of kidney diseases 77 (3), 440-453, 2021 | 138 | 2021 |
| Membranous nephropathy and malignancy LH Beck Jr Seminars in nephrology 30 (6), 635-644, 2010 | 121 | 2010 |
| Anti-phospholipase A2 receptor antibodies in recurrent membranous nephropathy A Kattah, R Ayalon, LH Beck Jr, S Sethi, DG Sandor, FG Cosio, ... American Journal of Transplantation 15 (5), 1349-1359, 2015 | 108 | 2015 |
| Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial AS Bomback, PA Canetta, LH Beck Jr, R Ayalon, J Radhakrishnan, ... American journal of nephrology 36 (1), 58-67, 2012 | 108 | 2012 |
| PLA2R and THSD7A: disparate paths to the same disease? LH Beck Jr Journal of the American Society of Nephrology 28 (9), 2579-2589, 2017 | 102 | 2017 |
| Membranous nephropathy associated with IgG4-related disease P Cravedi, M Abbate, E Gagliardini, M Galbusera, S Buelli, E Sabadini, ... American Journal of Kidney Diseases 58 (2), 272-275, 2011 | 100 | 2011 |
| Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study SA Timmermans, JGMC Damoiseaux, PTJ Heerings-Rewinkel, R Ayalon, ... American journal of clinical pathology 142 (1), 29-34, 2014 | 94 | 2014 |
